Cargando…

Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma

Gliomas are the most common malignant primary brain tumors in adults with poor prognoses. The purpose of this study is to explore CACNG3 as a prognostic factor that is closely related to the progression and survival outcome of gliomas and to provide a potential new molecular target for the diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shan, Enfang, Cao, Yi-nan, Zhang, Yang, Chen, Wen, Ren, Xurui, Zhu, Shanjie, Xi, Xueru, Mu, Shuai, Ma, Mian, Zhi, Tongle, Li, Xianwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494363/ https://www.ncbi.nlm.nih.gov/pubmed/37697240 http://dx.doi.org/10.1186/s12885-023-10896-1

Ejemplares similares

Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population
por: Lee, Jin Sol, et al.
Publicado: (2010)

Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis
por: Kanwar, Nisha, et al.
Publicado: (2020)

Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis
por: Zimu, Zhou, et al.
Publicado: (2021)

Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients
por: Li, Hainan, et al.
Publicado: (2021)

RETRACTED ARTICLE: Inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6
por: Wang, Wei, et al.
Publicado: (2019)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma
por: Liu, Zhen-Yuan, et al.
Publicado: (2023)

Prognostic and Predictive Biomarkers in Gliomas
por: Śledzińska, Paulina, et al.
Publicado: (2021)

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity
por: Gong, Yiyang, et al.
Publicado: (2023)

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
por: Dong, Jiawei, et al.
Publicado: (2023)

Patients with Dilated Cardiomyopathy and Sustained Monomorphic Ventricular Tachycardia Show Up-Regulation of KCNN3 and KCNJ2 Genes and CACNG8-Linked Left Ventricular Dysfunction
por: Ortega, Ana, et al.
Publicado: (2015)

miR-339 Promotes Hypoxia-Induced Neuronal Apoptosis and Impairs Cell Viability by Targeting FGF9/CACNG2 and Mediating MAPK Pathway in Ischemic Stroke
por: Gao, Xiao-Zeng, et al.
Publicado: (2020)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

Identifying Prognostic Significance of RCL1 and Four-Gene Signature as Novel Potential Biomarkers in HCC Patients
por: Liu, Jun, et al.
Publicado: (2021)

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas
por: Han, Ming-Zhi, et al.
Publicado: (2017)

A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
por: Xiang, Zijin, et al.
Publicado: (2021)

MAP3K8 Is a Prognostic Biomarker and Correlated With Immune Response in Glioma
por: Ren, Jing, et al.
Publicado: (2021)

Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s disease
por: Dong, Yue, et al.
Publicado: (2018)

Identifying network biomarkers based on protein-protein interactions and expression data
por: Xin, Jingxue, et al.
Publicado: (2015)

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
por: Yang, Shu, et al.
Publicado: (2022)

Aging-related genes are potential prognostic biomarkers for patients with gliomas
por: Xiao, Gelei, et al.
Publicado: (2021)

Stanniocalcin 1 is a prognostic biomarker in glioma
por: Luo, Weijian, et al.
Publicado: (2020)

MAPK Activated Protein Kinase 3 Is a Prognostic-Related Biomarker and Associated With Immune Infiltrates in Glioma
por: Ren, Jing, et al.
Publicado: (2021)

Molecular cloning of the gene promoter encoding the human Ca(V)γ(2)/Stargazin divergent transcript (CACNG2-DT): characterization and regulation by the cAMP-PKA/CREB signaling pathway
por: Muñoz-Herrera, David, et al.
Publicado: (2023)

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma
por: Wang, Feng, et al.
Publicado: (2022)

Temporal Muscle Thickness is an Independent Prognostic Biomarker in Patients with Glioma: Analysis of 261 Cases
por: Yan, Ou Ying, et al.
Publicado: (2021)

Regulatory Architecture of the Neuronal Cacng2/Tarpγ2 Gene Promoter: Multiple Repressive Domains, a Polymorphic Regulatory Short Tandem Repeat, and Bidirectional Organization with Co-regulated lncRNAs
por: Corney, B.P.A., et al.
Publicado: (2018)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer
por: Wang, Kai, et al.
Publicado: (2022)

Circadian Clock Genes Act as Diagnostic and Prognostic Biomarkers of Glioma: Clinic Implications for Chronotherapy
por: Chai, Ruihuan, et al.
Publicado: (2022)

CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma
por: Xu, Zhixing, et al.
Publicado: (2023)

ARL3 is downregulated and acts as a prognostic biomarker in glioma
por: Wang, Yulin, et al.
Publicado: (2019)

Human TERT promoter mutations as a prognostic biomarker in glioma
por: Powter, Branka, et al.
Publicado: (2021)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

Prognostic biomarker SYK and its correlation with immune infiltrates in glioma
por: Wang, Changxin, et al.
Publicado: (2023)

Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
por: Ren, Xiaoyue, et al.
Publicado: (2023)

F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma
por: Pong, Winnie W., et al.
Publicado: (2013)

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
por: Xiong, Ye, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9e28iju4fntthgulhi1ohiu8vb